[The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate].

Autor: Chibichyan MB; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia., Chernogubova EA; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia., Avetyan AV; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia., Lapteva TO; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia., Pavlenko IA; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia., Kogan MI; Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University of the Ministry of Health of the Russian Federation, Rostov-on-Don, Russia.; Federal State Budgetary Instituton of science Federal Research Center Southern Scientific Center of the Russian Academy of Sciences, Rostov-on-Don, Russia.; Federal State Budgetary Educational Institution National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Rostov-on-Don, Russia.; State budgetary institution of the Rostov region Anatomical Pathology Bureau, Rostov-on-Don, Russia.

Publikováno v: Urologiia (Moscow, Russia : 1999) [Urologiia] 2022 Mar (1), pp. 5-10.

[Role of angiotensin II receptor type 2 in predicting biochemical recurrence in the treatment of prostate cancer].

Autor: Chibichyan MB; Institute of Arid Zones of Southern Scientific Center of RAS, Rostov-on-Don.; Rostov State Medical University, Rostov-on-Don., Kogan MI; Institute of Arid Zones of Southern Scientific Center of RAS, Rostov-on-Don.; Rostov State Medical University, Rostov-on-Don., Chernogubova EA; Institute of Arid Zones of Southern Scientific Center of RAS, Rostov-on-Don.; Rostov State Medical University, Rostov-on-Don., Pavlenko IA; Rostov Region Pathology and Autopsy Bureau, Rostov-on-Don., Matishov DG; Institute of Arid Zones of Southern Scientific Center of RAS, Rostov-on-Don.

Publikováno v: Urologiia (Moscow, Russia : 1999) [Urologiia] 2016 Dec (6), pp. 89-94.

[Specific features of gene amplification on the long arm of chromosome 17 in different molecular genetic subtypes of breast cancer].

Autor: Zavalishina LE, Danilova NV, Matsionis AE, Pavlenko IA

Publikováno v: Arkhiv patologii [Arkh Patol] 2014 Mar-Apr; Vol. 76 (2), pp. 8-12.

[A FISH analysis in one day. Experience in evaluating HER2 gene status by means of a new HER2 IQFISH pharmdx kit].

Autor: Zavalishina LÉ, Petrov AV, Pavlenko IA, Gorelik MZ

Publikováno v: Arkhiv patologii [Arkh Patol] 2013 Jan-Feb; Vol. 75 (1), pp. 52-3.

[Bcl-2 as a prognostic factor in different molecular genetic subtypes of breast cancer].

Autor: Pavlenko IA, Povilaĭtite PE, Gorelik MZ, Petrov AV

Publikováno v: Arkhiv patologii [Arkh Patol] 2012 Sep-Oct; Vol. 74 (5), pp. 36-40.